BridgeBio Pharma, Inc.BBIONASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank88
3Y CAGR+14.8%
5Y CAGR+9.9%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+14.8%/yr
vs -3.6%/yr prior
5Y CAGR
+9.9%/yr
Recent acceleration
Acceleration
+18.4pp
Accelerating
Percentile
P88
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $570.12M | -16.3% |
| 2024 | $681.10M | +81.2% |
| 2023 | $375.94M | -0.2% |
| 2022 | $376.69M | -4.3% |
| 2021 | $393.77M | +10.6% |
| 2020 | $356.08M | -2.1% |
| 2019 | $363.77M | -16.6% |
| 2018 | $436.09M | +374.0% |
| 2017 | $92.00M | - |